TITLE

Leukocyte reduction in cardiovascular surgery

AUTHOR(S)
Morris, S.
PUB. DATE
September 2001
SOURCE
Perfusion;Sep2001, Vol. 16 Issue 5, p371
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the use of leucocyte reduction filters in cardiopulmonary bypass (CPB) surgery. Development of leukocyte filters; Effect of leukocyte reduction on bleeding/blood transfusions; Leukocyte reduction of blood cardioplegia; Leukocyte reduction in lung transplantation.
ACCESSION #
5842281

 

Related Articles

  • Cardiopulmonary bypass (CPB) for lung transplantation. Hlozek, C.C.; Smedira, N.G.; Kirby, T.J.; Patel, A.N.; Perl, M. // Perfusion;1997, Vol. 12 Issue 2, p107 

    Surgeons have often been reluctant to use cardiopulmonary bypass (CPB) during single (SLTx) and double lung (DLTx) transplantation surgery because of the potential adverse sequelae of CPB including haemorrhage and activation of complement leading to sequestration of neutrophils and platelets in...

  • Efficacy of leukocyte depletion of residual pump blood. Heerdt, E. M.; Fransen, E. J.; Maessen, J. G.; de Jong, D. S. // Perfusion;Jan2004, Vol. 19 Issue 1, p3 

    In this study, we examined whether leukocyte depletion from the residual heart-lung machine blood at the end of cardiopulmonary bypass (CPB) has an effect on the leukocyte counts in the systemic circulation. Twenty-six patients undergoing coronary artery bypass grafting (CABG) were randomly...

  • Retrospective analysis of effect of low-dose aprotinin priming on allogeneic blood transfusion in repeated cardiac operations. Miyashita, T.; Hayashi, Y.; Ohnishi, Y.; Kuro, M. // Perfusion;1999, Vol. 14 Issue 3, p189 

    The objective of this retrospective study was to investigate efficacy of low-dose aprotinin priming therapy on the requirement of allogeneic transfusion and to identify risk factors for allogeneic transfusion in patients undergoing repeated cardiac operations. The present study includes a...

  • Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model. Kim, W.G.; Lee, B-H.; Seo, J.W. // Perfusion;May2001, Vol. 16 Issue 3, p207 

    An experiment to study the role of contact-activation leukocyte sequestration in the formation of ischaemia-reperfusion injury (I-R injury) was carried out. The study was conducted using light and electron microscopic analyses in an ovine cardiopulmonary bypass (CPB) model using a membrane...

  • Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Olivencia-Yurvati, AH; Ferrara, CA; Tierney, N; Wallace, N; Mallet, RT // Perfusion;Jan2003 Supplement, Vol. 18, p23 

    Cardiopulmonary bypass (CPB) precipitates inflammation that causes marked pulmonary dysfunction. Leukocyte filtration has been proposed to reduce these deleterious effects. Other studies show an improvement with aprotinin. We proposed that a combination of these two therapies would...

  • Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations Bittner, Hartmuth B.; Binner, Christian; Lehmann, Sven; Kuntze, Thomas; Rastan, Ardawan; Mohr, Friedrich W. // European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p462 

    Abstract: Objective: Cardiopulmonary bypass (CPB) support is required in some lung transplantation (LTX) operations. CPB support and full-dose heparin increases the risks of bleeding and early graft dysfunction. We report our experiences of replacing CPB with heparin-bonded low-dose heparin...

  • Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation. Gott, J. // Perfusion;Mar2001 Supplement 1, Vol. 16, p5 

    Most cardiac operations involve the use of extracorporeal circulation with its attendant systemic inflammatory response syndrome. Many anti-inflammatory strategies hold promise for reducing the associated morbidity of cardiopulmonary bypass. The application of pharmacological and mechanical...

  • Timing of leukocyte filtration during cardiopulmonary bypass. Matheis, G.; Scholz, M.; Simon, A.; Henrich, D.; Wimmer-Greinecker, G.; Moritz, A. // Perfusion;Mar2001 Supplement 1, Vol. 16, p31 

    The effects of leukocyte filtration on the outcome of cardiac surgery with cardiopulmonary bypass (CPB) have been shown by numerous investigators. In the majority of cases a leukocyte filter is placed in the arterial line instead of a standard arterial line filter and used throughout CPB....

  • Leukocyte filtration in cardiac surgery: a review. Matheis, G.; Scholz, M.; Simon, A.; Dzemali, O.; Moritz, A. // Perfusion;Sep2001, Vol. 16 Issue 5, p361 

    Leukocyte filtration has evolved as an important technique in cardiac surgery with cardiopulmonary bypass to prevent pathogenic effector functions mediated by activated leukocytes. The underlying mechanisms that result in an improvement of laboratory variables as well as clinical outcome are not...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics